Home
About Journal
Editorial Board
Instruction
Subscribe
Download
Contact Us
Chinese
中国医学创新
2024
,
Vol. 21
Issue (26)
: 32-35
DOI
: 10.3969/j.issn.1674-4985.2024.26.008
Clinical research
Current Issue
|
Archive
|
Adv Search
|
Effect and Safety of Pertuzumab in the Treatment of Patients with HER2-positive Breast Cancer
DONG Zhengyu
First-author's address: Department of Oncology, Yancheng Second People's Hospital, Yancheng 224003, China
Abstract
Figure/Table
References
Related Citation (15)
Download:
PDF
(1075 KB)
HTML
(1 KB)
Export:
BibTeX
|
EndNote
(RIS)
Received:
26 January 2024
Service
E-mail this article
Add to my bookshelf
Add to citation manager
E-mail Alert
RSS
Articles by authors
DONG Zhengyu
Cite this article:
DONG Zhengyu. Effect and Safety of Pertuzumab in the Treatment of Patients with HER2-positive Breast Cancer[J]. 中国医学创新, 2024, 21(26): 32-35.
URL:
http://www.zgyxcx.com/EN/10.3969/j.issn.1674-4985.2024.26.008
OR
http://www.zgyxcx.com/EN/Y2024/V21/I26/32
[1]
SHAN Yaofei,Mayinuer·Maimaitiming,HU Jiajun.
Comparison of the Effects of Ultrasound-guided Microwave Ablation and Radiofrequency Ablation on Thyroid Function and Safety in Patients with Benign Thyroid Nodules
[J]. 中国医学创新, 2024, 21(8): 33-37.
© 2016 中国医学创新 editorial
Address: Beijing south cellular road number five Postcodes: 100055